HUNTINGTON BEACH, Calif., August 06, 2025--BiVACOR, Inc., a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its TAH ...

HUNTINGTON BEACH, Calif., August 06, 2025--BiVACOR, Inc., a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its TAH ...

BiVACOR ® is a clinical-stage medical device company developing a fully implantable, magnetically levitated Total Artificial Heart for long-term support of patients with end-stage biventricular ...

"Cardiac Assist Devices Market Insights, Competitive Landscape, and Market Forecast - 2030"The Cardiac Assist Devices market, ...

According to Dr Arabia, early versions of the TAH were meant to replace the human heart permanently. However, although the technology has vastly improved, TAH is still considered a temporary measure ...

Centerline Biomedical, Inc., a Cleveland-based medtech company, has appointed Jim Dillon its new president and CEO, replacing ...

Centerline Biomedical, Inc. ("Centerline"), an innovative leader in cardiovascular navigation and visualization systems, ...

Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...

Ten breakthrough Brisbane health companies are gearing up for global expansion after being selected to join the city’s flagship MedTech Global Accelerator.